Jicheng Lv

18.6k total citations · 6 hit papers
231 papers, 9.9k citations indexed

About

Jicheng Lv is a scholar working on Nephrology, Immunology and Hematology. According to data from OpenAlex, Jicheng Lv has authored 231 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Nephrology, 53 papers in Immunology and 52 papers in Hematology. Recurrent topics in Jicheng Lv's work include Renal Diseases and Glomerulopathies (150 papers), Chronic Kidney Disease and Diabetes (62 papers) and Platelet Disorders and Treatments (40 papers). Jicheng Lv is often cited by papers focused on Renal Diseases and Glomerulopathies (150 papers), Chronic Kidney Disease and Diabetes (62 papers) and Platelet Disorders and Treatments (40 papers). Jicheng Lv collaborates with scholars based in China, United States and Romania. Jicheng Lv's co-authors include Luxia Zhang, Vlado Perkovic, Hong Zhang, Bruce Neal, Sufang Shi, Anthony Rodgers, Alan Cass, Toshiharu Ninomiya, Lijun Liu and Hong Zhang and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jicheng Lv

219 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Worldwide access to treatment for end-stage kidney disease: a systematic review

2015 1.5k citations Jicheng Lv et al. profile →
Prevalence and Disease Burden of Chronic Kidney Disease

2019 694 citations Jicheng Lv et al. profile →
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

2010 656 citations Jicheng Lv et al. profile →
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

2015 619 citations Xinfang Xie, Jicheng Lv et al. profile →
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

2012 560 citations Jicheng Lv et al. profile →
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

2015 296 citations Xinfang Xie, Lijun Liu et al. profile →

Peers

Jicheng Lv

NEPHR

CCM

SURGE

IMMUN

EDM

Shin‐Wook Kang South Korea

Kunihiro Yamagata Japan

Xueqing Yu China

David Goldsmith United Kingdom

Jérôme Rossert France

Kosaku Nitta Japan

Adrian Covic Romania

Tae‐Hyun Yoo South Korea

Seung Hyeok Han South Korea

Piero Ruggenenti Italy

Shin‐Wook Kang South Korea

Jicheng Lv

6.1k ×1.2

NEPHR

1.4k ×0.8

CCM

1.7k ×1.2

SURGE

964 ×0.7

IMMUN

1.3k ×1.0

EDM

Citations per year, relative to Jicheng Lv Jicheng Lv (= 1×) peers Shin‐Wook Kang

Countries citing papers authored by Jicheng Lv

Since Specialization

Citations

This map shows the geographic impact of Jicheng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jicheng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jicheng Lv more than expected).

Fields of papers citing papers by Jicheng Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jicheng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jicheng Lv. The network helps show where Jicheng Lv may publish in the future.

Co-authorship network of co-authors of Jicheng Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jicheng Lv. A scholar is included among the top collaborators of Jicheng Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jicheng Lv. Jicheng Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xianzhi, Xiaohan Yuan, Lijun Liu, et al.. (2025). Complement C3 and complement factor H affect glomerular IgA deposition in IgA nephropathy. Immunobiology. 230(4). 153018–153018.

Xu, Lu, Pei Chen, Sufang Shi, et al.. (2025). External Validation of the Post-Biopsy International IgA Nephropathy Prediction Tool Models over Extended Follow-Up in an Asian Cohort. Kidney Diseases. 11(1). 661–673.

Wu, Jingyi, Yuemiao Zhang, Zhao Zhang, et al.. (2025). B Cell-Specific Deletion of C1GALT1 Elevates Serum Gd-IgA1 but Fails to Induce Mesangial IgA Deposition in Humanized IGHA1 Mice. Journal of the American Society of Nephrology. 36(10S).

Wong, Muh Geot, Dana Kim, Sufang Shi, et al.. (2025). Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 20(11). 1564–1570.

Li, Zhu, Xinfang Xie, Xu Zhang, et al.. (2024). Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model. Journal of the American Society of Nephrology. 36(1). 60–72. 1 indexed citations

Tang, Chen, Pei Chen, Linlin Xu, et al.. (2024). Circulating Proteins and IgA Nephropathy. Journal of the American Society of Nephrology. 35(8). 1045–1057. 8 indexed citations

Qi, Yuanyuan, Yuemiao Zhang, Céline C. Berthier, et al.. (2024). A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy. International Immunopharmacology. 131. 111920–111920. 2 indexed citations

Qi, Yuanyuan, Yuemiao Zhang, Yang Li, et al.. (2024). Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis. International Immunopharmacology. 132. 111905–111905. 5 indexed citations

Li, Xiang, Ting Wang, Ying Xu, et al.. (2024). B-Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy. Journal of the American Society of Nephrology. 35(12). 1686–1701. 5 indexed citations

10.

Tang, Chen, Jicheng Lv, Sufang Shi, et al.. (2023). Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis. American Journal of Nephrology. 54(5-6). 234–244. 6 indexed citations

11.

Kang, Yuqi, Boyang Xu, Sufang Shi, et al.. (2023). Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 18(12). 1583–1591. 10 indexed citations

12.

Tang, Chen, Pei‐Jer Chen, Yuxuan Yao, et al.. (2023). Intensive blood pressure control and the progression of IgA nephropathy: a cohort study using marginal structural models. Nephrology Dialysis Transplantation. 39(1). 55–63. 3 indexed citations

13.

Yuan, Xiaohan, Qing Su, Hui Wang, et al.. (2022). Genetic Variants of the COL4A3, COL4A4, and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients. Journal of the American Society of Nephrology. 34(1). 132–144. 14 indexed citations

14.

Li, Jingyi, Ling Guo, Sufang Shi, et al.. (2022). The Role of Complement in Microangiopathic Lesions of IgA Nephropathy. Kidney International Reports. 7(6). 1219–1228. 12 indexed citations

15.

Zhou, Shu‐Feng, Lam C. Tsoi, Yong Hu, et al.. (2021). Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese. Clinical Journal of the American Society of Nephrology. 16(2). 213–224. 12 indexed citations

16.

Zhou, Shu‐Feng, Pei‐Jer Chen, Guizhen Yu, et al.. (2021). Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy. Journal of the American Society of Nephrology. 32(3). 545–552. 24 indexed citations

17.

Xie, Xinfang, Pan Liu, Jicheng Lv, et al.. (2021). Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine. JCI Insight. 6(19). 7 indexed citations

18.

He, Jiawei, Shu‐Feng Zhou, Yafeng Li, et al.. (2021). Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy. mSystems. 6(1). 31 indexed citations

19.

Zhou, Shu‐Feng, et al.. (2020). Identification of Key Genes of Human Advanced Diabetic Nephropathy Independent of Proteinuria by Transcriptome Analysis. BioMed Research International. 2020(1). 7283581–7283581. 6 indexed citations

20.

Chen, Qi, Zi Wang, Zhenjie Chen, et al.. (2020). Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes. Clinical Journal of the American Society of Nephrology. 15(11). 1576–1586. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact